BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34390226)

  • 1. Cognitive changes and brain connectomes, endocrine status, and risk genotypes in testicular cancer patients-A prospective controlled study.
    Buskbjerg CR; Amidi A; Agerbaek M; Gravholt CH; Hosseini SH; Zachariae R
    Cancer Med; 2021 Sep; 10(18):6249-6260. PubMed ID: 34390226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in newly orchiectomized testicular cancer patients.
    Buskbjerg CR; Zachariae R; Agerbæk M; Gravholt CH; Haldbo-Classen L; Hosseini SMH; Amidi A
    Brain Imaging Behav; 2022 Feb; 16(1):199-210. PubMed ID: 34392471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen deprivation therapy and cognitive decline-associations with brain connectomes, endocrine status, and risk genotypes.
    Buskbjerg CR; Amidi A; Buus S; Gravholt CH; Hadi Hosseini SM; Zachariae R
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):208-218. PubMed ID: 34088994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in patients with newly diagnosed prostate cancer referred to androgen-deprivation therapy.
    R Buskbjerg C; Zachariae R; Buus S; H Gravholt C; Haldbo-Classen L; Hosseini SMH; Amidi A
    Cancer; 2021 May; 127(9):1495-1506. PubMed ID: 33351221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment.
    Amidi A; Agerbæk M; Wu LM; Pedersen AD; Mehlsen M; Clausen CR; Demontis D; Børglum AD; Harbøll A; Zachariae R
    Brain Imaging Behav; 2017 Jun; 11(3):769-783. PubMed ID: 27240852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients.
    Amidi A; Wu LM; Agerbæk M; Larsen PL; Pedersen AD; Mehlsen M; Larsen L; Zachariae R
    Psychooncology; 2015 Sep; 24(9):1174-80. PubMed ID: 25851607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of neuropsychological functioning in testicular cancer patients.
    Skaali T; Fosså SD; Andersson S; Cvancarova M; Langberg CW; Lehne G; Dahl AA
    Ann Oncol; 2011 May; 22(5):1062-1070. PubMed ID: 21048038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study.
    Pozza C; Pofi R; Tenuta M; Tarsitano MG; Sbardella E; Fattorini G; Cantisani V; Lenzi A; Isidori AM; Gianfrilli D;
    Hum Reprod; 2019 Aug; 34(8):1389-1403. PubMed ID: 31532522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.
    Overman MJ; Pendleton N; O'Neill TW; Bartfai G; Casanueva FF; Forti G; Rastrelli G; Giwercman A; Han TS; Huhtaniemi IT; Slowikowska-Hilczer J; Lean ME; Punab M; Lee DM; Antonio L; Gielen E; Rutter MK; Vanderschueren D; Wu FC; Tournoy J
    Physiol Behav; 2022 Aug; 252():113825. PubMed ID: 35487276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor.
    Wiechno PJ; Kowalska M; Kucharz J; Sadowska M; Michalski W; Poniatowska G; Jońska-Gmyrek J; Rzymkowska J; Nietupski K; Demkow T
    Med Oncol; 2017 May; 34(5):84. PubMed ID: 28389909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of common genetic variants in cognitive decline in the first seven years of Parkinson's disease: A longitudinal observational study.
    Chung J; Ushakova A; Doitsidou M; Tzoulis C; Tysnes OB; Dalen I; Pedersen KF; Alves G; Maple-Grødem J
    Neurosci Lett; 2021 Nov; 764():136243. PubMed ID: 34509566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
    Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
    Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of cognitive function in men with non-seminomatous germ cell tumors.
    Wefel JS; Vidrine DJ; Marani SK; Swartz RJ; Veramonti TL; Meyers CA; Hoekstra HJ; Hoekstra-Weebers JE; Gritz ER
    Psychooncology; 2014 Jun; 23(6):626-33. PubMed ID: 24339329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress.
    Skaali T; Fosså SD; Andersson S; Cvancarova M; Langberg CW; Lehne G; Dahl AA
    J Psychosom Res; 2011 May; 70(5):403-10. PubMed ID: 21511070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous hormones, androgen receptor CAG repeat length and fluid cognition in middle-aged and older men: results from the European Male Ageing Study.
    Lee DM; Ulubaev A; Tajar A; Pye SR; Pendleton N; Purandare N; O'Neill TW; O'Connor DB; Labrie F; Platt H; Payne D; Bartfai G; Boonen S; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Silman AJ; Vanderschueren D; Wu FC;
    Eur J Endocrinol; 2010 Jun; 162(6):1155-64. PubMed ID: 20231367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Brain Structural Networks and Cognitive Functions in Testicular Cancer Patients Receiving Cisplatin-Based Chemotherapy.
    Amidi A; Hosseini SMH; Leemans A; Kesler SR; Agerbæk M; Wu LM; Zachariae R
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29617869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
    Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
    J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor CAG repeat length as a moderator of the relationship between free testosterone levels and cognition.
    Tan S; Porter T; Bucks RS; Weinborn M; Milicic L; Brown A; Rainey-Smith SR; Taddei K; Ames D; Masters CL; Maruff P; Savage G; Rowe CC; Villemagne VL; Brown B; Sohrabi HR; Laws SM; Martins RN;
    Horm Behav; 2021 May; 131():104966. PubMed ID: 33714752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive abilities, brain white matter hyperintensity volume, and structural network connectivity in older age.
    Wiseman SJ; Booth T; Ritchie SJ; Cox SR; Muñoz Maniega S; Valdés Hernández MDC; Dickie DA; Royle NA; Starr JM; Deary IJ; Wardlaw JM; Bastin ME
    Hum Brain Mapp; 2018 Feb; 39(2):622-632. PubMed ID: 29139161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.